Clinical Trials in Minneapolis

Showing 5641-5660 of 14,456 trials

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

NCT05705505

This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.

Endometrioid Endometrial Cancer

Traws Pharma, Inc.60 participantsStarted Mar 2023

Tucson, Arizona, United States • Minneapolis, Minnesota, United States • Mineola, New York, United States +5 more locations

COMPLETEDPhase 2< 1 mile

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

NCT03538301

A phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, biological activity, and pharmacokinetics (PK) of ND-L02-s0201 for Injection in subjects with IPF.

Idiopathic Pulmonary Fibrosis

Nitto Denko Corporation123 participantsStarted Jun 2018

Tucson, Arizona, United States • Los Angeles, California, United States • Northridge, California, United States +30 more locations

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

Find Trials by Condition in Minneapolis

MAP to Health Pilot Study: A Physical Activity Intervention for Midlife Adults

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Approaches and Decisions for Acute Pediatric TBI Trial

Efficacy and Safety of BIIB111 for the Treatment of Choroideremia

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) Study Multi-Center Study

Genetics of the Early and Late Response to Allergen Challenge

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Furosemide as Supportive Therapy for COVID-19 Respiratory Failure

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

Examine the Psychosocial Impacts of COVID-19 Pandemic.